BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 28223794)

  • 1. Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.
    Baines KJ; Fu JJ; McDonald VM; Gibson PG
    Int J Chron Obstruct Pulmon Dis; 2017; 12():541-550. PubMed ID: 28223794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway IL-1β and Systemic Inflammation as Predictors of Future Exacerbation Risk in Asthma and COPD.
    Fu JJ; McDonald VM; Baines KJ; Gibson PG
    Chest; 2015 Sep; 148(3):618-629. PubMed ID: 25950204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of sputum biomarkers for asthma-COPD overlap syndrome.
    Gao J; Iwamoto H; Koskela J; Alenius H; Hattori N; Kohno N; Laitinen T; Mazur W; Pulkkinen V
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2457-2465. PubMed ID: 27757028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.
    Lacedonia D; Palladino GP; Foschino-Barbaro MP; Scioscia G; Carpagnano GE
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1811-1817. PubMed ID: 28694694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exacerbations and health care resource utilization in patients with airflow limitation diseases attending a primary care setting: the PUMA study.
    Montes de Oca M; Aguirre C; Lopez Varela MV; Laucho-Contreras ME; Casas A; Surmont F
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3059-3067. PubMed ID: 27994446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe exacerbations in moderate-to-severe asthmatics are associated with increased pro-inflammatory and type 1 mediators in sputum and serum.
    Ghebre MA; Pang PH; Desai D; Hargadon B; Newby C; Woods J; Rapley L; Cohen SE; Herath A; Gaillard EA; May RD; Brightling CE
    BMC Pulm Med; 2019 Aug; 19(1):144. PubMed ID: 31395050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A score to predict short-term risk of COPD exacerbations (SCOPEX).
    Make BJ; Eriksson G; Calverley PM; Jenkins CR; Postma DS; Peterson S; Östlund O; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():201-9. PubMed ID: 25670896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sputum ADAM8 expression is increased in severe asthma and COPD.
    Oreo KM; Gibson PG; Simpson JL; Wood LG; McDonald VM; Baines KJ
    Clin Exp Allergy; 2014 Mar; 44(3):342-52. PubMed ID: 24147597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.
    Miravitlles M; García-Sidro P; Fernández-Nistal A; Buendía MJ; Espinosa de Los Monteros MJ; Esquinas C; Molina J
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2571-9. PubMed ID: 26664105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CODEXS: A New Multidimensional Index to Better Predict Frequent COPD Exacerbators with Inclusion of Depression Score.
    Deng D; Zhou A; Chen P; Shuang Q
    Int J Chron Obstruct Pulmon Dis; 2020; 15():249-259. PubMed ID: 32099350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drop in lung function during asthma and COPD exacerbations - can it be assessed without spirometry?
    Melbye H; Al-Ani S; Spigt M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3145-3152. PubMed ID: 27994453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study.
    Reilev M; Lykkegaard J; Halling A; Vestbo J; Søndergaard J; Pottegård A
    NPJ Prim Care Respir Med; 2017 Apr; 27(1):25. PubMed ID: 28416794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers.
    Bafadhel M; McKenna S; Terry S; Mistry V; Reid C; Haldar P; McCormick M; Haldar K; Kebadze T; Duvoix A; Lindblad K; Patel H; Rugman P; Dodson P; Jenkins M; Saunders M; Newbold P; Green RH; Venge P; Lomas DA; Barer MR; Johnston SL; Pavord ID; Brightling CE
    Am J Respir Crit Care Med; 2011 Sep; 184(6):662-71. PubMed ID: 21680942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clustering approach to identify and characterize the asthma and chronic obstructive pulmonary disease overlap phenotype.
    Hirai K; Shirai T; Suzuki M; Akamatsu T; Suzuki T; Hayashi I; Yamamoto A; Akita T; Morita S; Asada K; Tsuji D; Inoue K; Itoh K
    Clin Exp Allergy; 2017 Nov; 47(11):1374-1382. PubMed ID: 28658564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
    Patel AR; Kowlessar BS; Donaldson GC; Mackay AJ; Singh R; George SN; Garcha DS; Wedzicha JA; Hurst JR
    Am J Respir Crit Care Med; 2013 Nov; 188(9):1091-9. PubMed ID: 24033321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Sputum 6 Gene Expression Signature Predicts Inflammatory Phenotypes and Future Exacerbations of COPD.
    Baines KJ; Negewo NA; Gibson PG; Fu JJ; Simpson JL; Wark PAB; Fricker M; McDonald VM
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1577-1590. PubMed ID: 32669843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying a gene expression signature of frequent COPD exacerbations in peripheral blood using network methods.
    Morrow JD; Qiu W; Chhabra D; Rennard SI; Belloni P; Belousov A; Pillai SG; Hersh CP
    BMC Med Genomics; 2015 Jan; 8():1. PubMed ID: 25582225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
    Dilektasli AG; Demirdogen Cetinoglu E; Uzaslan E; Budak F; Coskun F; Ursavas A; Ercan I; Ege E
    Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.